College of Management and Economics, Tianjin University, Tianjin 300072, China.
Int J Environ Res Public Health. 2022 Mar 2;19(5):2928. doi: 10.3390/ijerph19052928.
The innovation and development practices of the pharmaceutical industry are of great importance for the continual enhancement of public health. Industrial clusters are one of the important means by which the pharmaceutical industry can be transformed and developed, but there is a lack of research on the evolutionary path and development innovation of pharmaceutical industrial clusters. As a country with a major pharmaceutical industry, the transformation and development path of traditional pharmaceutical industrial clusters in China has important reference value for the sustainable development of the global pharmaceutical industry. Through an analysis of the evolution of traditional pharmaceutical industrial clusters in Shijiazhuang, this study explores the law of the dynamic evolution of pharmaceutical industrial clusters and the associated mechanisms. Specifically, we conclude that the evolutionary path of traditional pharmaceutical industrial clusters can be divided into the government-led pharmaceutical industrial cluster start-up stage, the government-guided pharmaceutical industrial cluster development stage, and the government-served pharmaceutical industrial cluster transformation stage. The operating mechanisms include a self-organization mechanism, an innovation-driven mechanism, and an outward associated mechanism, each of which plays different roles in the different stages of the dynamic evolution of the cluster, and the synergistic operation of the three mechanisms forms an important basis for the evolution of pharmaceutical industrial clusters. We found that the innovation development of traditional pharmaceutical industrial clusters is influenced by the synergy of the self-organization, innovation-driven, and outward associated mechanisms. The self-organization mechanism is a necessary condition for pharmaceutical industrial clusters to realize the transition from disorder to order. The innovation-driven mechanism is the core driving force for the innovative development of pharmaceutical industrial clusters. Finally, the outward associated mechanism is the main means by which pharmaceutical industrial clusters integrate into the global value chain.
制药业的创新和发展实践对不断提高公众健康水平具有重要意义。产业集群是制药业转型升级的重要手段之一，但对于制药产业集群的演进路径和发展创新研究还比较缺乏。中国作为一个制药大国，其传统制药产业集群的转型发展路径对全球制药产业的可持续发展具有重要的参考价值。本文通过对石家庄传统制药产业集群的演进分析，探讨了制药产业集群的动态演进规律及其内在机制。具体而言，我们得出结论，传统制药产业集群的演进路径可以分为政府主导的制药产业集群启动阶段、政府引导的制药产业集群发展阶段和政府服务的制药产业集群转型阶段。其运行机制包括自组织机制、创新驱动机制和外向关联机制，每个机制在集群动态演进的不同阶段发挥着不同的作用，三个机制的协同作用构成了制药产业集群演进的重要基础。我们发现，传统制药产业集群的创新发展受到自组织、创新驱动和外向关联机制协同作用的影响。自组织机制是制药产业集群实现由无序到有序转变的必要条件。创新驱动机制是制药产业集群创新发展的核心动力。最后，外向关联机制是制药产业集群融入全球价值链的主要手段。
